Original article
Creatine-kinase and dialysis patients, a helpful tool for stratifying cardiovascular risk?
Creatincinasa y pacientes en diálisis, ¿una herramienta útil para estratificar el riesgo cardiovascular?
Borja Quiroga
, Almudena Vega, Soraya Abad, Maite Villaverde, Javier Reque, Juan Manuel López-Gómez
Autor para correspondencia
Servicio de Nefrología, Hospital General Universitario Gregorio Marañón, Madrid, Spain
Leído
12474
Vecesse ha leído el artículo
3064
Total PDF
9410
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 25 | 3 | 28 |
| 2025 5 | 152 | 41 | 193 |
| 2025 4 | 115 | 22 | 137 |
| 2025 3 | 178 | 58 | 236 |
| 2025 2 | 133 | 36 | 169 |
| 2025 1 | 99 | 43 | 142 |
| 2024 12 | 78 | 22 | 100 |
| 2024 11 | 88 | 54 | 142 |
| 2024 10 | 53 | 30 | 83 |
| 2024 9 | 73 | 22 | 95 |
| 2024 8 | 77 | 65 | 142 |
| 2024 7 | 58 | 31 | 89 |
| 2024 6 | 69 | 36 | 105 |
| 2024 5 | 56 | 35 | 91 |
| 2024 4 | 68 | 51 | 119 |
| 2024 3 | 46 | 28 | 74 |
| 2024 2 | 38 | 32 | 70 |
| 2024 1 | 45 | 29 | 74 |
| 2023 12 | 38 | 20 | 58 |
| 2023 11 | 72 | 38 | 110 |
| 2023 10 | 83 | 39 | 122 |
| 2023 9 | 55 | 25 | 80 |
| 2023 8 | 58 | 33 | 91 |
| 2023 7 | 64 | 32 | 96 |
| 2023 6 | 103 | 18 | 121 |
| 2023 5 | 102 | 27 | 129 |
| 2023 4 | 80 | 11 | 91 |
| 2023 3 | 92 | 26 | 118 |
| 2023 2 | 84 | 18 | 102 |
| 2022 1 | 41 | 34 | 75 |
| 2022 12 | 73 | 27 | 100 |
| 2022 11 | 69 | 53 | 122 |
| 2022 10 | 73 | 43 | 116 |
| 2022 9 | 56 | 33 | 89 |
| 2022 8 | 67 | 55 | 122 |
| 2022 7 | 38 | 59 | 97 |
| 2022 6 | 62 | 46 | 108 |
| 2022 5 | 65 | 47 | 112 |
| 2022 4 | 59 | 60 | 119 |
| 2022 3 | 70 | 56 | 126 |
| 2022 2 | 61 | 44 | 105 |
| 2021 1 | 47 | 51 | 98 |
| 2021 12 | 72 | 49 | 121 |
| 2021 11 | 63 | 48 | 111 |
| 2021 10 | 76 | 46 | 122 |
| 2021 9 | 59 | 49 | 108 |
| 2021 8 | 115 | 30 | 145 |
| 2021 7 | 49 | 42 | 91 |
| 2021 6 | 54 | 32 | 86 |
| 2021 5 | 63 | 37 | 100 |
| 2021 4 | 96 | 58 | 154 |
| 2021 3 | 79 | 54 | 133 |
| 2021 2 | 75 | 11 | 86 |
| 2020 1 | 58 | 18 | 76 |
| 2020 12 | 59 | 19 | 78 |
| 2020 11 | 58 | 16 | 74 |
| 2020 10 | 28 | 30 | 58 |
| 2020 9 | 49 | 14 | 63 |
| 2020 8 | 60 | 15 | 75 |
| 2020 7 | 49 | 14 | 63 |
| 2020 6 | 33 | 28 | 61 |
| 2020 5 | 77 | 28 | 105 |
| 2020 4 | 54 | 23 | 77 |
| 2020 3 | 45 | 22 | 67 |
| 2020 2 | 64 | 20 | 84 |
| 2020 1 | 69 | 48 | 117 |
| 2019 12 | 53 | 36 | 89 |
| 2019 11 | 53 | 31 | 84 |
| 2019 10 | 26 | 25 | 51 |
| 2019 9 | 33 | 23 | 56 |
| 2019 8 | 30 | 23 | 53 |
| 2019 7 | 15 | 21 | 36 |
| 2019 6 | 32 | 30 | 62 |
| 2019 5 | 38 | 20 | 58 |
| 2019 4 | 88 | 38 | 126 |
| 2019 3 | 51 | 31 | 82 |
| 2019 2 | 32 | 18 | 50 |
| 2019 1 | 20 | 27 | 47 |
| 2018 12 | 229 | 40 | 269 |
| 2018 11 | 472 | 25 | 497 |
| 2018 10 | 366 | 31 | 397 |
| 2018 9 | 97 | 19 | 116 |
| 2018 8 | 66 | 15 | 81 |
| 2018 7 | 50 | 16 | 66 |
| 2018 6 | 62 | 19 | 81 |
| 2018 5 | 118 | 8 | 126 |
| 2018 4 | 132 | 20 | 152 |
| 2018 3 | 147 | 15 | 162 |
| 2018 2 | 141 | 13 | 154 |
| 2018 1 | 86 | 10 | 96 |
| 2017 12 | 123 | 9 | 132 |
| 2017 11 | 73 | 12 | 85 |
| 2017 10 | 62 | 9 | 71 |
| 2017 9 | 41 | 11 | 52 |
| 2017 8 | 42 | 11 | 53 |
| 2017 7 | 62 | 14 | 76 |
| 2017 6 | 64 | 15 | 79 |
| 2017 5 | 77 | 10 | 87 |
| 2017 4 | 58 | 13 | 71 |
| 2017 3 | 43 | 17 | 60 |
| 2017 2 | 38 | 17 | 55 |
| 2016 1 | 17 | 15 | 32 |
| 2016 12 | 73 | 7 | 80 |
| 2016 11 | 84 | 23 | 107 |
| 2016 10 | 119 | 15 | 134 |
| 2016 9 | 128 | 11 | 139 |
| 2016 8 | 149 | 5 | 154 |
| 2016 7 | 217 | 12 | 229 |
| 2016 6 | 115 | 0 | 115 |
| 2016 5 | 202 | 0 | 202 |
| 2016 4 | 165 | 0 | 165 |
| 2016 3 | 179 | 0 | 179 |
| 2016 2 | 195 | 0 | 195 |
| 2015 1 | 59 | 0 | 59 |
| 2015 12 | 21 | 0 | 21 |
Mostrar todo
